___

• Akhondzadeh, S., Noroozian, M., Mohammadi, M.
• Ohadinia, S., Jamshidi, A.H., Khani M. (2003). Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer’s disease: a double blind, randomised, placebo controlled trial. Journal of Neurology Neurosurgery and Psychiatry, 74, 863–866.
• Alzheimer Europe. (2012). The prevalence of dementia in Europe for Turkey. Erişim: 03.02.2015.
• http://www.alzheimer-europe.org/Policy-in Practice2/Country dementia-in-Europe/Turkey
• Amerikan Alzheimer Derneği (American Azheimer’s Association). (2014). Alzheimer’s disease facts and figures, Alzheimer’s & Dementia, Volume 10, Issue 2.
• Ballard, C. G., O’Brien, J. T., James, I., Mynt, P., Lana, M., Potkins, D. et al. (2001). Quality of life for people with dementia living in residental and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills and psychotropic drugs. International Psychogeriatrics, 13, 93- 106.
• Ballard, C. G., O’Brien, J. T., Reichelt, K., Perry, E. K. (2002). Aromatherapy as a safe of a double-blind, placebo-controlled trial with Melissa. Journal of Clinical Psychiatry, 63, 553–558.
• Barlett, H., Gray, L., Byrne, G., Travers, C., Lui, C. (2006), Dementia a national health priority, dementia research mapping project final report. Commonwealth Department of Health and Ageing, Queensland, Australia. 82-101.
• Bowles, E. J., Griffiths, D. M., Quirk, L., Brownrigg A., Croot K. (2002). Effects of essential oils and touch on resistance to nursing care procedures and other dementia related behaviours in a residential care facility. International Journal of Aromatherapy, 12, 22–29.
• Burns, A., Perry, E., Holmes, C., Francis, P., Morris, J., Howes, M.J. et al. (2011). A double-blindplacebo- controlled randomized trial of Melissa officinalis oil and donepezil for the treatment of agitation in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 1(2), 158-64. Byrne, G.J. (2005).
• Pharmacological treatment of behavioural problems in dementia. Australian Prescriber, 28, 67–70.
• Capezuti, E., Zwicker, D., Mezey, M., Fulmer, T. (2008). Evidence based geriatric nursing protocols for best practice. (3rd ed., pp 127)., Springer Publishing Company, New York.
• Cerejeira, J., Lagarto, L., Mukaetova-Ladinska, E.B. (2012). Behavioral and psychologicalsymptoms of dementia. Frontiers in Neurology. 3 (73), 1- 21.
• Cipriani, G., Vedovello, M., Nuti, A., Di Fiorino, M. (2012). Aggressive behavior in patients with dementia: correlates and management. Geriatrics Gerontology International, 11(4), 408-413.
• Douglas, S., James, I., Ballard, C. (2004). Non- pharmacological interventions in dementia. The Royal College of Psychiatrists, 10, 171- 177.
• Dünya Sağlık Örgütü (DSÖ). World Health Organization (WHO). (2012). Dementia: a public health priority. Erişim: http://whqlibdoc.who.int/publications/2012/97892415644 58_eng.pdf 24.02.15.
• Eker, E. (2009). Alzheimer Hastalığında davranış ve psikolojik Nöropsikiyatri Dergisi, 1, 1-10. Geriatri ve Geriatrik
• Forrester, L.T., Maayan, N., Orrell, M., Spector, A.E, Buchan, L.D., Soares-Weiser, K. (2014).Aromatherapy for dementia. Cochrane Database of Systematic Reviews, Issue 2.
• Fujii, M., Hatakeyama, R., Fukuoka, Y., Yamamoto, T., Sasaki, R., Moriya, M., Kanno, M., Sasaki
• H. (2008). Lavender aroma therapy for behavioral and psychological symptoms in dementia patients. Geriatrics Gerontology International, 8, 136- 138.
• Fung, J. K., Tsang, H., Chung, R. (2012). A systematic review of the use of aromatherapy intreatment of behavioral problems in dementia. Geriatrics Gerontology International, 12, 372- 382.
• Gaugler, J.E., Wall, M.M., Kane, R.L., Menk, J.S., Sarsour, K., Johnston, J.A. et al. (2011). Does
• caregiver burden mediate the effects of behavioral disturbances on nursing home admission? American Journal of Geriatric Psychiatry, 19(6), 497-506.
• Genç, L. (2010). Tıbbi ve aromatik bitkilerin kullanım alanları ve etiği. Anadolu Üniversitesi Yayınları Eskişehir: Web-Ofset Tesisleri, ISBN: 978-975-06-0779- 0, 09/2010. Erişim: 31.12.13. http://ue.anadolu.edu.tr/Tab/Dersler/Sayfalar/TAB203U. aspx
• Givens, J.L., Mezzacappa, C., Heeren, T., Yaffe, K., Fredman, L. (2014). Depressive symptoms among dementia caregivers: role of mediating factors. American Journal of Geriatric Psychiatry, 22, 481-488.
• Goff, M. (1993). Caring for a person with dementia in acute hospitals. Australian Nursing Journal,7(10), 1- 4.
• Gray, S. G., Clair, A. A. (2002). Influence of aromatherapy on medication administration toresidential-care residents with dementia and behavioural challenges. American Journal of Alzheimer’s Disease and Other Dementias, 17, 169- 174.
• Greve, M., O’Connor, D. (2005). A survey of Australian and New Zealand old age psychiatrists’preferred medications to treat behavioral and psychological symptoms Psychogeriatrics, 17, 195-205. (BPSD). International
• Hebert, L.E., Weuve, J., Scherr, P.A., Evans, D.A. (2013). Alzheimer disease in the United States(2010-2050) estimated using the 2010 census. Neurology, 80(19), 1778- 1783.
• Holmes, C., Ballard, C. (2004). Aromatherapy in dementia. The Royal College of Psychiatrists, 10, 296- 300.
• Holmes, C., Hopkins, V., Hensford C., MacLaughlin, V., Wilkinson, D., Rosenvinge, H. (2002)Lavender oil as a treatment for agitated behaviour in severe dementia: a placebo controlled study. Internatıonal Journal of Geriatric Psychiatry, 17, 305- 308.
• Hongo, T., Kawai, S., Kamoshita, H., Kurata, M. (2013) Efficacy of aromatherapy for dementia. Journal of Health and Sports Science Juntendo, 4(1), 1-9.
• Huang, L., Abuhamdah, S., Howes, M.J., Dixon, C.L., Elliot, M.S., Ballard, C. et all. (2008).Pharmacological profile of essential oils derived from Lavandula angustifolia and Melissa officinalis with anti-agitation properties: focus on ligand-gated channels. Journal of Pharmacy and Pharmacology, 60(11), 1515-22.
• Işık, A., Tanrıdağ, O. (2009) Geriatri pratiğinde Demans Sendromu: Geriatrik sendromlar dizisi. (4.1. Basım). İstanbul: Özal Matbaa.
• Kim, H., Chang, M., Rose, K., Kim, S. (2012). Predictors of caregiver burden in caregivers ofindividuals with dementia. Journal of Advanced Nursing, 68(4), 846–855.
• Küçükgüçlü, Ö., Akpınar, B., Buckwalter, K.C. (2011). Demansı olan bireyde davranışsalproblemleri azaltmada kanıta dayalı bir model: azalmış stres eşiği modeli. DEUHYO ED 2011, 4 (1), 41-47.
• Lewis, S., Heitkemper, M., Dirksen, M. O’Brien P., Bucher, L. (2007). Medical surgical nursing(7rd Edt., Volume 2 Section 11): Alzheimer’s disease and dementia (pp. 1561- 1579). Philadelphia: Mosby.
• Lin, P.W., Chan, W. C., Ng, B. F., Lam, L. C. (2007). Efficacy of aromatherapy (Lavandulaangustifolia) as an intervention for agitated behaviours in Chinese older persons with dementia: a cross- over randomized trial. International Journal of Geriatric Psychiatry, 22, 405- 410.
• Matthiesen, V., Lamb, K., McCann, J., Hollinger- Smith, L., Walton, J. (1996). Hospital nursesviews about physical restraints Gerontological Nursing, 22, 8-16. older patients. Journal of
• McShane, R., Keene, J., Gedling, K., Fairburn C., Jacoby R., Hope T. (1997). Do neuroleptic drugshasten cognitive decline in dementia? Prospective study with necropsy follows up. BMJ, 314 (7076), 266- 270.
• Miller, C. (1997). Nursing care of older adults: theory and practice (3rd edt.) Philadelphia:Lippincott, 531-580.
• Nguyen, Q.A., Paton, C. (2008). The use of aromatherapy to treat behavioral problems in dementia.International Journal of Geriatric Psychiatry, 23, 337–346.
• O’Neil, M., Freeman, M., Christensen, V., Telerant, A., Addleman, A., Kansagara, D. (March2011). Non- pharmacological interventions for behavioral symptoms of dementia: a systematic review of the evidence. Erişim: 24.02.15. http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH001020 6/
• Ornstein, K., Gaugler, J. E. (2012). The problem with “problem behaviors”: a systematic review of the association between individual patient behavioral and psychological symptoms and caregiver depression and burden within the dementia patient-caregiver dyad. International Psychogeriatrics, 24(10), 1536–1552.
• Özel- Kızıl, E. T., Baştuğ, G., Erdoğan, S., Sakarya, D., Durmaz, N. (2012). Demans hastalarındaCohen- Mansfield ajitasyon envanterinin Türkçe uyarlamasının psikometrik özellikleri. Turkish Journal of Geriatrics, 15 (1), 24- 29.
• Pioli, M.F. (2010). Global and caregiving mastery as moderators in the caregiving stress process.Aging Mental Health, 14(5), 603-612.
• Ploeg, E. S., Eppingstall, B., O’Connor, D. W. (2010). The study protocol of a blinded randomized-controlled cross- over trial of lavender oil as a treatment of behavioral symptoms in dementia. BMC Geriatrics, 10, 49.
• Prince, M., Bryce, R., Albanese, E., Wimo, A., Ribeiro, W., Ferri, C.P. (2013). The globalprevalence of dementia: a systematic review and meta-analysis. Alzheimer’s & Dementia, 9, 63-75.
• Qui, C., De Ronchi, D., Fratiglioni, L. (2007). The epidemiology of the dementias: an update,Current Opinion in Psychiatry, 20, 380- 385.
• Royal Collage of Psychiatrists. (2009). Dementia fact sheet. Erişim: 24.02.14.
• http://www.rcpsych.ac.uk/mentalhealthinfo/alzheimersandd ementia/dmentiakeyfacts.aspx
• Schneider, L. S., Tariot, P. N., Dagerman, K. S., Davis, S. M., Hsiao, J. K., Ismail M.S. et all. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. The New England Journal of Medicine, 355, 1525- 1538.
• Selbaek, G., Kirkevold, O., Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioral disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22(9), 843- 849.
• Smallwood, J., Brown, R., Coulter, F., Irvine, E., Copland, C. (2001). Aromatherapy and behaviour disturbances in dementia: a randomized controlled trial. International Journal of Geriatric Psychiatry, 16, 1010-1013.
• Snow, L. A., Hovanec, L., Brandt, J. (2004). A controlled trial of aromatherapy for agitation innursing home patients with dementia. The Journal of Alternative and Complementary Medicine, 10(3), 431- 437.
• Sourial, R., McCusker, J., Cole, M., Abrahamowicz, M. (2001). Agitation in demented patients in an acute care hospital: prevalence, disruptiveness, and staff burden. International Psychogeriatrics, 13(2), 183-197.
• Sullivan-Marx, E. M. (2001). Achieving restraint-free care of acutely confused older adults.Journal of Gerontological Nursing, 27(4), 56-61.
• The 10/66 Dementia Research Group. (2004). Behavioral and psychological symptoms of dementiain developing countries. International Psychogeriatrics, 16(4), 441- 459.
• Wolfs, C.A., Kessels, A., Severens, J.L., Brouwer, W., de Vugt, M.E., Verhey, F.R. et all. (2012).Predictive factors for the objective burden of informal care in people with dementia: a systematic review. Alzheimer Disease and Associated Disorders, 26(3), 197-204.
• Wooltorton, E. (2004). Olanzapine (Zyprexa): increased incidence of cerebrovascular events indementia trials. Canadian Medical Association Journal, 170, 1395.
• Wooltorton, E.(2004). Risperidone (Risperdal): increased rate of cerebrovascular events indementia trials. Canadian Medical Association Journal, 167, 1269-1270.
• Yavuz- Balam, B., Arıoğlu, S. (2008). Yaşlıda demans, risk faktörleri ve tedavisi. İç Hastalıkları Dergisi, 15(1), 14- 23.
• Yılmaz, A., Turan, E. (2008). Alzheimer hastalarının yakınlarında bakımevi tercihini belirleyenfaktörler. Kriz Dergisi, 16(2), 11-24.
• Yılmaz, A., Turan, E., Gündoğar, D. (2009). Predictors of burnout in the family caregivers ofAlzheimer’s disease: Evidence from Turkey. Australasian Journal on Ageing, 28(1), 16-21.
• Yu Fu, C., Moyle, W., Cooke, M. (2013). A randomised controlled trial of the use of aromatherapy and hand massage to reduce disruptive behavior in people with dementia. Medicine, 13, 165. and Alternative